Author(s):Professor David Nutt, Professor Celia Morgan, Dr Laurie Higbed, Professor Jan Melichar
Duration:75 minutes
Credits:1.25
Published:June 2022
Type:Congress webinar
Addiction treatments have progressed little in the past 30 years. This session presents some exciting new approaches: the use of ketamine and MDMA to disrupt the brain processes of alcohol adduction and depot buprenorphine to provide enduring cover for heroin addiction. if more widely accepted these may significantly improve treatment outcomes in the future.
Chair: Professor David Nutt, Imperial College London
Ketamine assisted therapy – the results of the new KARE trial in alcohol use disorder - Professor Celia Morgan, Exeter University and Awaknlifesciences
MDMA assisted psychotherapy for alcohol use disorder - Dr Laurie Higbed, Imperial College London
Drowning on daily opioids to floursihing on long-acting injectable buprenorphine: a Welsh pandemic success story - Professor Jan Melichar, Wales NHS
Find more content
